For which of the following cardiac lesions is endocarditis prophylaxis not advised before dental procedures: completely repaired congenital heart defects during the 6 months after repair, valve stenosis on echocardiography, left ventricular assist devices (LVAD) or implantable heart devices, or surgical or transcatheter pulmonary artery valve or conduit placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is "Valve stenosis on echocardiography." Endocarditis prophylaxis is not routinely advised for patients with valve stenosis detected on echocardiography alone. Prophylaxis is recommended for the other listed high-risk cardiac conditions: completely repaired congenital heart defects during the first 6 months after repair, left ventricular assist devices or implantable hearts, and surgical or transcatheter pulmonary artery valve or conduit placement. These other conditions carry higher risk of adverse outcomes from infective endocarditis. The current guidelines have become more restrictive, focusing prophylaxis only on patients with the highest risk of adverse outcomes from endocarditis rather than those with any valvular abnormality. Valve stenosis without other risk factors does not meet the threshold for prophylaxis according to current recommendations 1.

Key Points

  • The American Heart Association (AHA) guidelines have become more restrictive, focusing on patients with the highest risk of adverse outcomes from endocarditis.
  • Prophylaxis is recommended for high-risk cardiac conditions, including:
    • Completely repaired congenital heart defects during the first 6 months after repair
    • Left ventricular assist devices or implantable hearts
    • Surgical or transcatheter pulmonary artery valve or conduit placement
  • Valve stenosis on echocardiography alone does not meet the threshold for prophylaxis according to current recommendations.
  • The guidelines emphasize the importance of maintaining optimal oral health and hygiene to reduce the incidence of bacteremia from daily activities, rather than relying on prophylactic antibiotics for dental procedures 1.

From the Research

Cardiac Lesions and Endocarditis Prophylaxis

  • Completely repaired congenital heart defects during the 6 months after repair: according to 2, 3, endocarditis prophylaxis is not advised for completely repaired congenital heart defects during the 6 months after repair, unless they have a prosthetic valve or other high-risk conditions.
  • Valve stenosis on echocardiography: 3 states that native valvular disease is no longer a target for prophylaxis, implying that endocarditis prophylaxis is not advised for valve stenosis on echocardiography alone.
  • Left ventricular assist devices (LVAD) or implantable heart devices: there is no direct evidence in the provided studies to suggest that endocarditis prophylaxis is not advised for these devices, but 2 mentions that implanted prosthetic material can pave the way for cardiovascular device-related infections.
  • Surgical or transcatheter pulmonary artery valve or conduit placement: 4 discusses the risk of infective endocarditis after pulmonary valve replacement, but does not explicitly state that endocarditis prophylaxis is not advised before dental procedures for these patients. However, 3 implies that prophylaxis is only recommended for high-risk groups, and it is unclear if these patients would be considered high-risk.

High-Risk Conditions

  • Cyanotic congenital heart disease: 3 states that this is a high-risk condition for which endocarditis prophylaxis is recommended.
  • Valvular prosthesis: 3 states that this is a high-risk condition for which endocarditis prophylaxis is recommended.
  • Previous endocarditis: 3 states that this is a high-risk condition for which endocarditis prophylaxis is recommended.
  • High-velocity shunts like ventricular septal defect: 3 suggests that these should be included in the at-risk congenital disease for infective endocarditis where prophylaxis should be applied.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infective endocarditis in congenital heart disease.

European journal of pediatrics, 2011

Research

[Infective endocarditis prophylaxis in congenital heart disease].

Presse medicale (Paris, France : 1983), 2017

Research

Surgical therapy of infective endocarditis following interventional or surgical pulmonary valve replacement.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2021

Related Questions

What are the risk factors for endocarditis?
Which patients require antibiotic prophylaxis for endocarditis in dental procedures?
What is the recommended antibiotic prophylaxis for preventing endocarditis (infection of the inner lining of the heart) following a root canal procedure?
Under what circumstances is antibiotic prophylaxis (use of antibiotics to prevent infection) recommended before dental work?
What is the most common congenital heart disease associated with Infective Endocarditis (IE)?
In which patients with endocarditis is surgery required for optimal outcome, considering factors such as large (>10-mm) hypermobile vegetation, prior systemic embolus, significant valve dysfunction, persistent bacteremia despite optimal antimicrobial therapy, very large (>30-mm) vegetation, or poorly responsive endocarditis due to highly antibiotic-resistant organisms?
What is the role of the soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) ratio in neonates?
Does a Hepatobiliary Iminodiacetic Acid (HIDA) scan help diagnose acute cholecystitis?
What is not required for a clinical diagnosis of definite Infective Endocarditis (IE), according to the Harrison's Internal Medicine reference?
What is not a risk factor for prosthetic valve endocarditis after transcatheter aortic valve replacement (TAVR), considering options such as Diabetes, Female sex, Impaired renal function, and Moderate postimplantation aortic valve regurgitation?
Are females experiencing menarche (onset of menstruation) at a younger age?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.